![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 7
2022
Griese, Matthias; Kappler, Matthias; Stehling, Florian; Schulze, Johannes; Baden, Winfried; Koerner-Rettberg, Cordula; Carlens, Julia; Prenzel, Freerk; Nährlich, Lutz; Thalmeier, Andreas; Sebah, Daniela; Kronfeld, Kai; Rock, Hans; Ruckes, Christian; Olivier, Margarete; Zielen, Stefan; Bagheri-Potthof, Azadeh; Thome, Ulrich; Gebhardt, Julia; Mehl, Anna; Lau, Susanne Gabriele; Philipp, Utz; Kopp, Matthias; Stichtenoth, Guido; Sommerburg, Olaf; Stahl, Mirjam; Kitz, Richard; Rietschel, Christoph; Stock, Philippe; Ahrens, Frank; Hebestreit, Helge; Segerer, Florian; Brinkmann, Folke; Anne, Schlegtendal; Eismann, Claudia; Neuner, Dörthe; Witt, Sabine; Hengst, Meike; Feilcke, Maria; Babl, Jürgen; Stauffer, Gabriele; Nickolay, Tanja; Gorbulev, Stanislav; Anthony, Gisela; Stöhr, Linda; Vieweg, Laura; Strenge-Hesse, Anke; Wetzke, Martin; Seidl, Elias und Schwerk, Nicolaus
(23. Juli 2022):
Randomized controlled phase 2 trial of hydroxychloroquine in childhood interstitial lung disease.
In: Orphanet Journal of Rare Diseases, Bd. 17
[PDF, 942kB]
Hess, Georg; Huettmann, Andreas; Witzens-Harig, Mathias; Dreyling, Martin H.; Keller, Ulrich; Marks, Reinhard; Ernst, Thomas; Pott, Christiane; Viardot, Andreas; Frontzek, Fabian; Trautmann, Marcel; Ruckes, Christian; Deuster, Oliver; Rosenwald, Andreas; Theobald, Matthias und Lenz, Georg
(2022):
A phase II trial to evaluate the combination of pixantrone and obinutuzumab for patients with relapsed aggressive lymphoma: Final results of the prospective, multicentre GOAL trial.
In: British Journal of Haematology, Bd. 198, Nr. 3: S. 482-491
2021
Griese, Matthias; Stehling, Florian; Schwerk, Nicolaus; Rosewich, Martin; Jerkic, Pera-Silvija; Rock, Hans; Ruckes, Christian; Kronfeld, Kai; Sebah, Daniela; Wetzke, Martin und Seidl, Elias
(2021):
Hypersensitivity pneumonitis: Lessons from a randomized controlled trial in children.
In: Pediatric Pulmonology, Bd. 56, Nr. 8: S. 2627-2633
Krajnak, Slavomir; Decker, Thomas; Schollenberger, Lukas; Rose, Christian; Ruckes, Christian; Fehm, Tanja; Thomssen, Christoph; Harbeck, Nadia und Schmidt, Marcus
(2021):
Phase II study of metronomic treatment with daily oral vinorelbine as first-line chemotherapy in patients with advanced/metastatic HR+/HER2-breast cancer resistant to endocrine therapy: VinoMetro-AGO-B-046.
In: Journal of Cancer Research and Clinical Oncology, Bd. 147, Nr. 11: S. 3391-3400
2020
Griese, Matthias; Köhler, Meike; Witt, Sabine; Sebah, Daniela; Kappler, Matthias; Wetzke, Martin; Schwerk, Nicolaus; Emiralioglu, Nagehan; Kiper, Nural; Kronfeld, Kai; Ruckes, Christian; Rock, Hans; Anthony, Gisela und Seidl, Elias
(2020):
Prospective evaluation of hydroxychloroquine in pediatric interstitial lung diseases. Study protocol for an investigator-initiated, randomized controlled, parallel-group clinical trial.
In: Trials
21:307
[PDF, 760kB]
Hess, Georg; Wagner, Karola; Keller, Ulrich; La Rosee, Paul; Atta, Johannes; Hübel, Kai; Lerchenmueller, Christian; Schoendube, Daniel; Witzens-Harig, Mathias; Ruckes, Christian; Medler, Christoph; Oordt, Christina van; Klapper, Wolfram; Theobald, Matthias und Dreyling, Martin
(2020):
Final Results of a Phase I/II Trial of the Combination Bendamustine and Rituximab With Temsirolimus (BeRT) in Relapsed Mantle Cell Lymphoma and Follicular Lymphoma.
In: Hemasphere, Bd. 4, Nr. 3, e398
2017
Thomssen, Christoph; Decker, Thomas; Fehm, Tanja; Fuxius, Stefan; Harbeck, Nadia; Juhasz-Böss, Ingolf; Möbus, Volker; Seehase, Martina; Schollenberger, Lukas; Ruckes, Christian und Schmidt, Marcus
(2017):
A Phase II Study Of Metronomic Daily Oral Vinorelbine As First-Line Chemotherapy In Advanced/Metastatic Hormone Receptor Positive (Hr Plus )/Human Epidermal Growth Factor Receptor 2 Negative (Her2-) Breast Cancer Resistant To Endocrine Therapy: Vinometro.
In: Breast, Bd. 36:
S51-S51